Seminars in Oncology Nursing
Volume 23, Issue 2 , Pages 142-151 , May 2007

Treatment-Related Symptom Clusters

References 

  1. American Cancer Society. Cancer facts and figures 2007. Atlanta, GA: American Cancer Society; 2007;
  2. Kim H-J, McGuire D, Tulman L, et al. Symptom clusters: concept analysis and clinical implications for cancer nursing. Cancer Nurs. 2005;28:270–282
  3. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28:465–470
  4. Fleishman S. Management of symptom clusters: pain, depression and fatigue. J Natl Cancer Inst Monogr. 2004;32:119–123
  5. Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34–43
  6. Berger AM, Parker KP, Young-McCaughan S, et al. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum. 2005;32:E98–E126
  7. Bender CM, Ergyn FS, Rosenzweig MQ, et al. Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nurs. 2005;28:219–225
  8. Beck SL, Dudley WN, Barsevick A. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster. Oncol Nurs Forum. 2005;32:E48–E55
  9. Dodd MJ, Miaskowski C, Lee KA. Occurrence of symptom clusters. J Natl Cancer Inst Monogr. 2004;32:76–78
  10. Gift AG, Jablonski A, Stommel M, et al. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31:202–212
  11. National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue. J Natl Cancer Inst Monographs. 2004;32:9–16July 15-17, 2002
  12. Cleeland CS, Bennett GJ, Dantzer R, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? (A cytokine-immunologic model of cancer symptoms). Cancer. 2003;97:2919–2925
  13. Given B, Given CW, Azzouz F, et al. Physical functioning in elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res. 2001;50:222–232
  14. Denham JW, O’Brien PC, Dunstan RH, et al. Is there more than one late radiation proctitis syndrome?. Radiother Oncol. 1999;51:43–53
  15. Cooley ME, Short TH, Moriarty HJ. Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncol. 2003;12:694–708
  16. Miaskowski C, Cooper BA, Paul SM, et al. Subgroups of patients with cancer with different symptom experiences and quality-of-life outcomes: a cluster analysis. Oncol Nurs Forum. 2006;33:E79–E89
  17. Sarna L, Evangelista L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125:439–445
  18. Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19:895–908
  19. Lehto RH, Cimprich B. Anxiety and directed attention in women awaiting breast cancer surgery. Oncol Nurs Forum. 1999;26:767–772
  20. Roberts SR, Early GL, Lamb J. Anxiety levels and cancer fear in patients admitted for elective operations. South Med J. 1990;83:1128–1130
  21. Jacox A, Carr DB, Payne R, et al. Management of cancer pain, clinical practice guideline. No. 9. AHCPR Publication No. 94-0592. Rockville, MD: U.S. Department of Health and Human Services; 1994;
  22. Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13:904–911
  23. Polovich M, White J, Kelleher L. Chemotherapy and Biotherapy Guidelines and Recommendations for Practice. Ed 2. Pittsburgh, PA: Oncology Nursing Society; 2005;
  24. Iop A, Manfredi AM, Bonura S. Fatigue in cancer patients receiving chemotherapy: an analysis of published studies. Ann Oncol. 2004;15:712–720
  25. Gift AG, Stommel M, Jablonski A, et al. A cluster of symptoms over time in patients with lung cancer. Nurs Res. 2003;52:393–400
  26. In:  Watkins Bruner D,  Haas M,  Gosselin-Acomb T editor. Manual for Radiation Oncology Nursing Practice and Education. Ed 3. Pittsburgh, PA: Oncology Nursing Society; 2005;
  27. Hunter MS, Grunfeld EA, Mittal S, et al. Menopausal symptoms in women with breast cancer: prevalence and treatment preferences. Psychooncol. 2004;13:769–778
  28. Carpenter JS, Andrykowski MA. Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum. 1999;26:1311–1317
  29. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8:474–487
  30. Nishimura K, Yamaguchi Y, Yamanaka M, et al. Climacteric-like disorders in prostate cancer patients treated with LHRH agonists. Arch Androl. 2005;51:41–48
  31. Morales L, Neven P, Timmerman D, et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs. 2004;15:753–760
  32. Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage. 1999;17:320–332
  33. Hickok J, Morrow G, Roscoe J, et al. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage. 2005;30:433–442
  34. Schwartz AL, Nail LM, Chen S, et al. Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest. 2000;18:11–19
  35. Ahsberg E, Furst CJ. Dimensions of fatigue during radiotherapy. Acta Oncol. 2001;40:37–43
  36. Biswal BM, Kumaraswamy N, Mukhtar F. Prevalence of fatigue among cancer patients undergoing external radiotherapy. Southeast Asian J Trop Med Public Health. 2004;35:463–467
  37. Williams PD, Ducey KA, Sears AM, et al. Treatment type and symptom severity among oncology patients by self-report. Int J Nurs Stud. 2001;38:359–367
  38. Robbins M, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol. 2004;80:251–259
  39. Weymuller EA, Yueh B, Deleyiannis FW, et al. Quality of life in head and neck cancer. Laryngoscope. 2000;110:4–7
  40. Chan CW, Richardson A, Richardson J. A study to assess the existence of the symptom cluster of breathlessness, fatigue and anxiety in patients with advanced lung cancer. Eur J Oncol Nurs. 2005;9:325–333
  41. Wang H, Huang E, Dale W, et al. Self-assessed health-related quality of life in men who have completed radiotherapy for prostate cancer: instrument validation and its relation to patient-assessed bother of symptoms. Int J Cancer. 2000;90:163–172
  42. Lee CM, Lee RJ, Handrahan DL, et al. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors. J Urol. 2005;65:114–119
  43. Widmark A, Fransson P, Franzen L, et al. Daily-diary evaluated side-effects of conformal versus conventional prostatic cancer radiotherapy technique. Acta Oncol. 1997;36:499–507
  44. Tait DM, Nahum AE, Meyer LC, et al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol. 1997;42:121–136
  45. Hovdenak N, Karlsdottir A, Sorbye H, et al. Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostate. Acta Oncol. 2003;42:741–748
  46. Long J, Versea L. Treatment approaches and nursing considerations for non-Hodgkin’s lymphoma. Semin Oncol Nurs. 2006;22:97–106
  47. Barsevick AM, Whitmer K, Nail LM, et al. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. 2006;31:85–95
  48. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000;89:1634–1646
  49. Cleeland CS. Cancer-related symptoms. Semin Radiat Oncol. 2000;10:175–190
  50. Portenoy RK, Thaler HT, Kornblith AB, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer. 1994;30A:1326–1336
  51. Chang VT, Hwang SS, Feuerman M, et al. The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000;89:1162–1171
  52. Tranmer JE, Heyland D, Dudgeon D, et al. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage. 2003;25:420–429
  53. Chang VT, Hwang SS, Kasimis B, et al. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest. 2004;22:526–536
  54. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248–257
  55. Catlin-Huth C, Haas M, Pollock V. Radiation Therapy Patient Care Record: A Tool for Documenting Nursing Care. Pittsburgh, PA: Oncology Nursing Society; 2002;
  56. Hollen PJ, Gralla RJ, Kris MG, et al. Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS). Support Care Cancer. 1999;7:140–148
  57. Hollen PJ, Gralla RJ, Kris MG, et al. A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?. Qual Life Res. 2005;14:837–847
  58. Berry DL, Trigg LJ, Lober WB, et al. Computerized symptom and quality-of-life assessment for patients with cancer (Part I: development and pilot testing). Oncol Nurs Forum. 2004;31:E75–E83
  59. Mooney KH, Beck SL, Friedman RH, et al. Telephone-linked care for cancer symptom monitoring: a pilot study. Cancer Pract. 2002;10:147–154
  60. National Comprehensive Cancer Network Clinical Practice guidelines in Oncology, Adult Cancer Pain. Vol 1. 2006;Available at: www.nccn.org.
  61. Practice guidelines for cancer pain management (A report by the American Society of Anesthesiologists Task Force on Pain Management, Cancer Pain Section). Anesthesiology. 1996;84:1243–1257
  62. Management of cancer pain guideline overview (Agency for Health Care Policy and Research, Rockville, MD). J Natl Med Assoc. 1994;86:571–573
  63. In:  Rodger J,  Winn M,  McClure J editor. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology, Cancer-Related Fatigue. Vol 1:2006;Version 1, Available at: www.nccn.org.
  64. Standards of Practice Committee of the American Academy of Sleep MedicineChesson AL, Anderson WM, Littner M, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia (An American Academy of Sleep Medicine report). Sleep. 1999;22:1128–1133
  65. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Anti-emesis. Version 2. 2006;Available at: www.nccn.org.
  66. Rubenstein EB, Peterson DE, Schubert M, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004;100(suppl):2026–2046
  67. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Distress Management. Vol. 1. 2007;Available at: www.nccn.org.
  68. Irwin R, Baumann M, Bolser D, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(suppl):1–23
  69. National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Fever and neutropenia. Vol. 1. 2006;Available at: www.nccn.org.
  70. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause. 2004;11:11–33
  71. Cancer Care Ontario. Telephone nursing practice and symptom management guidelines. Nursing Professional Advisory Committee. Cancer Care Ontario, 2004. Available at: http://www.cancercareontario.com/documents/NursingTelephonePracticeGuidelines.pdf (accessed March 30, 2007).

PII: S0749-2081(07)00012-5

doi: 10.1016/j.soncn.2007.01.002

Seminars in Oncology Nursing
Volume 23, Issue 2 , Pages 142-151 , May 2007

Article Tools

* Image Usage & Resolution